Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Eurofins Scientific SE
  6. News
  7. Summary
    ERF   FR0014000MR3

EUROFINS SCIENTIFIC SE

(ERF)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Eurofins Technologies Launches New Multiplex RT-PCR Respiratory Panel for SARS-CoV-2, Flu A, Flu B, RSV A and RSV B

12/01/2021 | 03:00am EST

Eurofins Technologies announced the launch of two RT-PCR assays to accurately diagnose respiratory diseases caused by SARS-CoV-2, Influenza virus or RSV. Since initial symptoms produced by these pathogens are indistinguishable, access to accurate and reliable tests will help clinicians improve patient care. These new CE-marked multiplex kits have been specifically designed to detect and differentiate three viral infections in the same PCR run. The Mplex SARS-CoV-2+, Flu A, Flu B (C1) RT-PCR assay facilitates differentiation, in a single reaction, between Influenza A, B, and SARS-CoV-2, with simultaneous detection of two SARS-CoV-2 targets (N-gene + RdRP gene) as recommended by the WHO. The RSV A, RSV B RT-PCR assay can differentiate between respiratory syncytial virus A and B. Both kits can be processed in parallel on the same plate, using the same temperature profile, and provide results in approximately 1 hour. An internal control (RNaseP) is included for adequate sample processing, and to monitor RNA extraction and the presence of potential inhibitors in the RT-PCR reaction. The AriaDxTM and AriaMxTM thermocyclers from Agilent Technologies are validated for both assays. ABI Prism? 7500 Fast SDS and QuantStudioTM 5 from Applied Biosystems?, CFX96 Touch? from Bio-Rad, and LightCycler? 480 II from Roche are validated for the RSV A, RSV B RT-PCR kit. Co-circulation of respiratory tract viruses during the COVID-19 pandemic poses unprecedented challenges to healthcare systems worldwide, and Eurofins Technologies endeavours to continue to provide high quality solutions for multi-pathogen testing.


ę S&P Capital IQ 2021
All news about EUROFINS SCIENTIFIC SE
01/25EUROFINS SCIENTIFIC : Managers' transactions - Director/PDMR Shareholding
PU
01/21EUROFINS SCIENTIFIC : Inside Information / Operations of the issuer (acquisitions, sales....
PU
01/21Eurofins’ empowerDX Launches PFAS Exposure™ in the U.S, the First at-Home Blo..
CI
01/17EUROFINS SCIENTIFIC : Managers' transactions - Director/PDMR Shareholding
PU
01/14Keysight Technologies' Test Tools Picked for 5G Device Validation Services in Taiwan
MT
01/11Eurofins CDMO Expands Spray Drying Capabilities
CI
01/11EUROFINS SCIENTIFIC : Managers' transactions - Director/PDMR Shareholding
PU
01/10EUROFINS SCIENTIFIC : Shares in Issue
PU
01/10European shares slide as rising yields hurt tech stocks
RE
01/07EUROFINS SCIENTIFIC : Managers' transactions - Director/PDMR Shareholding
PU
More news
Analyst Recommendations on EUROFINS SCIENTIFIC SE
More recommendations
Financials
Sales 2021 6 534 M 7 332 M 7 332 M
Net income 2021 801 M 898 M 898 M
Net Debt 2021 2 152 M 2 415 M 2 415 M
P/E ratio 2021 21,8x
Yield 2021 1,05%
Capitalization 16 922 M 19 093 M 18 990 M
EV / Sales 2021 2,92x
EV / Sales 2022 3,02x
Nbr of Employees 55 000
Free-Float 67,2%
Chart EUROFINS SCIENTIFIC SE
Duration : Period :
Eurofins Scientific SE Technical Analysis Chart | ERF | FR0014000MR3 | MarketScreener
Technical analysis trends EUROFINS SCIENTIFIC SE
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Last Close Price 88,02 €
Average target price 112,00 €
Spread / Average Target 27,2%
EPS Revisions
Managers and Directors
Gilles G. Martin Chairman & Chief Executive Officer
Laurent Lebras Director-Group Finance & Administration
Christian Wurst Chief Operating Officer-Food & Environment Testing
Stuart Anderson Independent Non-Executive Director
FÚrÚchtÚ Pouchantchi Independent Non-Executive Director
Sector and Competitors